A marriage of formal methods and LLMs seeks to harness the strengths of both.

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Finding the right book can make a big difference, especially when you’re just starting out or trying to get better. We’ve ...

A team of researchers has found a way to steer the output of large language models by manipulating specific concepts inside ...